Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
136 INR | -2.40% | +1.45% | -1.88% |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 359.9 | 258.9 | 146.5 | 1,176 | 897.8 | 576.2 |
Enterprise Value (EV) 1 | 361.2 | 301.1 | 268.3 | 1,282 | 1,010 | 671 |
P/E ratio | 11.8 x | 10.6 x | -118 x | -357 x | 18 x | -12.4 x |
Yield | 1.37% | 1.9% | - | - | - | - |
Capitalization / Revenue | 0.64 x | 0.56 x | 0.29 x | 1.71 x | 0.7 x | 0.57 x |
EV / Revenue | 0.65 x | 0.65 x | 0.52 x | 1.87 x | 0.79 x | 0.66 x |
EV / EBITDA | 6.14 x | 6.71 x | 9.35 x | 23.7 x | 5.06 x | 19.6 x |
EV / FCF | -11.8 x | -9.31 x | -5.22 x | - | -42.3 x | -5.22 x |
FCF Yield | -8.46% | -10.7% | -19.1% | - | -2.36% | -19.1% |
Price to Book | 0.98 x | 0.62 x | 0.33 x | 2.17 x | 1.51 x | 0.83 x |
Nbr of stocks (in thousands) | 4,917 | 4,917 | 4,917 | 4,917 | 4,917 | 5,900 |
Reference price 2 | 73.20 | 52.65 | 29.80 | 239.2 | 182.6 | 97.65 |
Announcement Date | 7/5/18 | 7/8/19 | 8/11/20 | 7/16/21 | 7/15/22 | 7/7/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 559 | 466.2 | 514 | 686.4 | 1,284 | 1,013 |
EBITDA 1 | 58.82 | 44.9 | 28.68 | 54.1 | 199.5 | 34.2 |
EBIT 1 | 43.22 | 29.89 | 11.37 | 36.79 | 162.1 | -5.379 |
Operating Margin | 7.73% | 6.41% | 2.21% | 5.36% | 12.62% | -0.53% |
Earnings before Tax (EBT) 1 | 42.36 | 30.16 | 2.49 | 27.05 | 156.9 | -8.385 |
Net income 1 | 30.57 | 24.49 | -1.238 | -3.292 | 49.78 | -47.51 |
Net margin | 5.47% | 5.25% | -0.24% | -0.48% | 3.88% | -4.69% |
EPS 2 | 6.217 | 4.980 | -0.2518 | -0.6695 | 10.12 | -7.900 |
Free Cash Flow 1 | -30.57 | -32.36 | -51.38 | - | -23.88 | -128.5 |
FCF margin | -5.47% | -6.94% | -10% | - | -1.86% | -12.69% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share 2 | 1.000 | 1.000 | - | - | - | - |
Announcement Date | 7/5/18 | 7/8/19 | 8/11/20 | 7/16/21 | 7/15/22 | 7/7/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 1.27 | 42.2 | 122 | 106 | 112 | 94.8 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 0.0215 x | 0.9408 x | 4.246 x | 1.953 x | 0.5633 x | 2.773 x |
Free Cash Flow 1 | -30.6 | -32.4 | -51.4 | - | -23.9 | -128 |
ROE (net income / shareholders' equity) | 8.62% | 6.24% | -0.29% | 2.06% | 12.7% | -2.11% |
ROA (Net income/ Total Assets) | 5.22% | 3.3% | 1.06% | 2.19% | 7.22% | -0.23% |
Assets 1 | 585.7 | 742.6 | -116.6 | -150.4 | 689.2 | 20,966 |
Book Value Per Share 2 | 74.90 | 84.80 | 90.70 | 110.0 | 121.0 | 117.0 |
Cash Flow per Share 2 | 0.3300 | 4.390 | 1.760 | 10.70 | 4.690 | 1.220 |
Capex 1 | 21 | 89.2 | 85.9 | - | 98.9 | 129 |
Capex / Sales | 3.75% | 19.14% | 16.71% | - | 7.7% | 12.74% |
Announcement Date | 7/5/18 | 7/8/19 | 8/11/20 | 7/16/21 | 7/15/22 | 7/7/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-1.88% | 9.85M | |
+24.28% | 44.74B | |
+33.09% | 23.36B | |
+25.28% | 16.24B | |
+20.67% | 14.39B | |
+68.66% | 13.96B | |
-0.05% | 6.79B | |
-13.04% | 6.4B | |
-8.87% | 5.73B | |
+13.36% | 5.68B |
- Stock Market
- Equities
- MAKERSL6 Stock
- Financials Makers Laboratories Limited